Our efforts to validate this model experimentally by silencing Par3 in patient-derived GBM cultures, do support a significant decrease in gliomasphere formation, an in vitro surrogate assay of self-renewal potential (Fig. 2 and Supplementary Fig. S2d). Here, PARD3 is linked to glioblastoma.